4-(4-Fluoro-phenyl)-3-oxo-butyric acid ethyl ester, 5g

n-[2-(dimethylamino)ethyl]pyridin-2-amine, 98%, 5g

(1R*,4R*)-N1-Cyclopentylcyclohexane-1,4-diamine dihydrochloride, 1g

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine, 95.0%, 25g

Tablet pans flat shape, , 120 mm, Height, 20 mm, 1 Piece

N-Acetyl-DL-histidine Monohydrate>98.0%(HPLC)(T)1g

N-[4-(Trifluoromethyl)benzyl]oxetan-3-amine, 1g

2-Isopropoxynicotinaldehyde, 95.0%, 1g

Ethyl (2E)-3-(5-formyl-1-methyl-1H-pyrrol-2-yl)-2-propenoate, 100mg

METHYL 4-((8-(HYDROXYAMINO)-8-OXOOCTANOYL)OXY)BENZOATE, 95%, 5mg

3-(Aminocarbonyl)pyrazine-2-carboxylic acid, 97.0%, 25g

1-Bromonaphthalen-2-ol, 95.0%, 1kg

2-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 96%, 1g